The Case for MDMA’s Approval Is Riddled With Problems

The results sounds promising, but Michael Ostacher, professor of psychiatry and behavioral sciences at Stanford University who’s not involved with Lykos and wasn’t on the FDA panel, says there’s a big problem: “It’s unclear whether or not the participation in…








